Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment

Macrophages are abundant in the tumor microenvironment (TME), serving as accomplices to cancer cells for their invasion. Studies have explored the biochemical mechanisms that drive pro-tumor macrophage functions, however the role of TME interstitial flow (IF) is often disregarded. Therefore, we developed a three-dimensional microfluidic-based model with tumor cells and macrophages to study how IF affects macrophage migration and its potential contribution to cancer invasion. The presence of either tumor cells or IF individually increased macrophage migration directedness and speed. Interestingly, there was no additive effect on macrophage migration directedness and speed under the simultaneous presence of tumor cells and IF. Further, we present an in silico model that couples chemokine-mediated signaling with mechanosensing networks to explain our in vitro observations. The model proposes IL-8, CCL2 and β-integrin as key pathways that commonly regulate various Rho GTPases. In agreement, in vitro macrophage migration remained elevated when exposed to a saturating concentration of recombinant IL-8 or CCL2, or to the co-addition of a sub-optimal concentration of both cytokines. Moreover, antibody blockade against IL-8 and/or CCL2 inhibited migration that could be restored by IF, indicating cytokine-independent mechanisms of migration induction. Importantly, we demonstrate the utility of an integrated in silico and 3D in vitro approach to aid the design of tumor-associated macrophage-based immunotherapeutic strategies.

[1]  Roger D. Kamm,et al.  Tumor cell migration in complex microenvironments , 2012, Cellular and Molecular Life Sciences.

[2]  Shu Chien,et al.  Role of integrins in endothelial mechanosensing of shear stress. , 2002, Circulation research.

[3]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[4]  E. Rofstad,et al.  Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI. , 2012, Cancer research.

[5]  J. Mege,et al.  Activation and Proteasomal Degradation of Rho GTPases by Cytotoxic Necrotizing Factor-1 Elicit a Controlled Inflammatory Response* , 2004, Journal of Biological Chemistry.

[6]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[7]  Tara A. Lee,et al.  Interstitial flow promotes macrophage polarization toward an M2 phenotype , 2018, Molecular biology of the cell.

[8]  Kristin E. Fink,et al.  Competition on the Nasdaq and the growth of electronic communication networks , 2006 .

[9]  F. Ginhoux,et al.  Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma , 2016, Oncoimmunology.

[10]  T. Wood,et al.  Differential Mechanisms of Recognition and Activation of Interleukin-8 Receptor Subtypes* , 1999, The Journal of Biological Chemistry.

[11]  M. Parmentier,et al.  Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events , 2008, Molecular Pharmacology.

[12]  Yang Li,et al.  Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma , 2016, International journal of molecular sciences.

[13]  Uri Alon,et al.  Proteome Half-Life Dynamics in Living Human Cells , 2011, Science.

[14]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[15]  Stephanie I. Fraley,et al.  A distinctive role for focal adhesion proteins in three-dimensional cell motility , 2010, Nature Cell Biology.

[16]  K Messmer,et al.  Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. , 1992, Cancer research.

[17]  Hongli Li,et al.  Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma , 2015, Cancer biology & therapy.

[18]  C. Dinney,et al.  Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Roger D. Kamm,et al.  A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. , 2017, Lab on a chip.

[20]  Matthew J. Craig,et al.  The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. , 2009, Neoplasia.

[21]  U. Alon An introduction to systems biology : design principles of biological circuits , 2019 .

[22]  Denis Wirtz,et al.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis , 2011, Nature Reviews Cancer.

[23]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[24]  I. Fidler,et al.  Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  Tara A. Lee,et al.  Interstitial flow promotes macrophage polarization toward an M2 phenotype , 2018, Molecular biology of the cell.

[26]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Beum Jun Kim,et al.  A contact line pinning based microfluidic platform for modelling physiological flows. , 2013, Lab on a chip.

[28]  Jeffrey Wyckoff,et al.  Cell migration in tumors. , 2005, Current opinion in cell biology.

[29]  H. Gutfreund,et al.  Enzyme kinetics , 1975, Nature.

[30]  D. Fearon,et al.  T cell exclusion, immune privilege, and the tumor microenvironment , 2015, Science.

[31]  Andrea Pavesi,et al.  Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model , 2018, Front. Immunol..

[32]  Roger D. Kamm,et al.  Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions , 2015, Oncotarget.

[33]  N. Rifai,et al.  Plasma inflammatory cytokines and survival of pancreatic cancer patients , 2018, Clinical and Translational Gastroenterology.

[34]  C. Abboud,et al.  Signal Pathway Regulation of Interleukin-8-Induced Actin Polymerization in Neutrophils , 1993 .

[35]  P. Johnston,et al.  Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer , 2005, Clinical Cancer Research.

[36]  S. Riethdorf,et al.  Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. , 1996, The American journal of pathology.

[37]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[38]  Roger D Kamm,et al.  Single-Cell Migration in Complex Microenvironments: Mechanics and Signaling Dynamics. , 2016, Journal of biomechanical engineering.

[39]  H. Pitt,et al.  Surgical management of pancreatic cancer. , 2002, Oncology.

[40]  H. Westerhoff,et al.  Recurrent design patterns in the feedback regulation of the mammalian signalling network , 2008, Molecular systems biology.

[41]  Matthew J. Craig,et al.  CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. , 2007, Neoplasia.

[42]  Michael Stumm,et al.  STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  R. Alon,et al.  Anti-inflammatory Effects of an Inflammatory Chemokine: Ccl2 Inhibits Lymphocyte Homing by Modulation of Ccl21-triggered Integrin-mediated Adhesions , 2008 .

[44]  M. Swartz,et al.  Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. , 2003, American journal of physiology. Heart and circulatory physiology.

[45]  L. Grøntved,et al.  Tumor-Associated Macrophages Derived from Circulating Inflammatory Monocytes Degrade Collagen through Cellular Uptake. , 2017, Cell reports.

[46]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[47]  R. Salgia,et al.  Chemokine Receptors CXCR-1/2 Activate Mitogen-activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells* , 2000, The Journal of Biological Chemistry.

[48]  Ricky T. Tong,et al.  Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. , 2007, Cancer research.

[49]  R. Kamm,et al.  Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels , 2012, Nature Protocols.

[50]  Roger D Kamm,et al.  Macrophage-Secreted TNFα and TGFβ1 Influence Migration Speed and Persistence of Cancer Cells in 3D Tissue Culture via Independent Pathways. , 2016, Cancer research.

[51]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[52]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Meng Sun,et al.  Modeling, signaling and cytoskeleton dynamics: integrated modeling‐experimental frameworks in cell migration , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.

[54]  W. Gillanders,et al.  Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma , 2017, Gut.

[55]  Kristen K. McCampbell,et al.  IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib , 2016, Oncotarget.

[56]  Y. Kanai,et al.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.

[57]  Brian Ingalls,et al.  Mathematical Modeling in Systems Biology: An Introduction , 2013 .

[58]  I. Charo,et al.  Differential Regulation of G-protein-mediated Signaling by Chemokine Receptors* , 1996, The Journal of Biological Chemistry.

[59]  G. Opdenakker,et al.  Chemotactic factors, passive invasion and metastasis of cancer cells. , 1992, Immunology today.

[60]  S. Natsugoe,et al.  Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. , 2011, The Journal of surgical research.

[61]  C. Ottensmeier,et al.  A plant-expressed conjugate vaccine breaks CD4+ tolerance and induces potent immunity against metastatic Her2+ breast cancer , 2016, Oncoimmunology.

[62]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[63]  Alan Wells,et al.  2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen , 2012, The Journal of cell biology.

[64]  Jürgen Weitz,et al.  Surgery Insight: surgical management of pancreatic cancer , 2007, Nature Clinical Practice Oncology.

[65]  L. Ivashkiv,et al.  IFN-γ and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways1 , 2008, The Journal of Immunology.

[66]  R K Jain,et al.  Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. , 1991, Cancer research.

[67]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. , 2000, Cancer research.

[68]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[69]  A. Biankin,et al.  CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype , 2018, Cell reports.

[70]  R. Jain,et al.  Perfusion of Single Tumor Microvessels: Application to Vascular Permeability Measurement , 1996, Microcirculation.

[71]  M Ancukiewicz,et al.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.

[72]  A. Ridley Rho GTPases and cell migration. , 2001, Journal of cell science.

[73]  M. Sherman,et al.  A Preliminary Report , 1953 .

[74]  J. Prados,et al.  Prognosis Relevance of Serum Cytokines in Pancreatic Cancer , 2015, BioMed research international.

[75]  辛島 尚 Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8 , 2004 .

[76]  Stefan Offermanns,et al.  Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.

[77]  Yang Zhang,et al.  Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner , 2014, BMC Cancer.

[78]  A. Andrews,et al.  Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity , 2017, Scientific Reports.

[79]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.

[80]  Yong-sheng Xiao,et al.  Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway. , 2015, International journal of oncology.

[81]  G. Soma,et al.  Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. , 2004, Anticancer research.

[82]  G. Stamp,et al.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. , 1995, The Journal of clinical investigation.

[83]  Melody A. Swartz,et al.  Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro , 2005, Journal of Cell Science.

[84]  Ying Lin,et al.  Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells , 2007, International journal of cancer.

[85]  S. Nathanson,et al.  Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma , 1994, Annals of Surgical Oncology.

[86]  Yarong Wang,et al.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.

[87]  Kinam Park,et al.  Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[88]  B. Rollins,et al.  CCL2 (monocyte chemoattractant protein-1) and cancer. , 2004, Seminars in cancer biology.

[89]  Roger D Kamm,et al.  Impact of the physical microenvironment on tumor progression and metastasis. , 2016, Current opinion in biotechnology.

[90]  C. Bakal,et al.  Mechanical and Systems Biology of Cancer , 2018, Computational and structural biotechnology journal.

[91]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[92]  L. Griffith,et al.  Transport‐mediated angiogenesis in 3D epithelial coculture , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution. , 1991, Microvascular research.

[94]  K. Matsushima,et al.  Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis , 2005, Nature Immunology.

[95]  B. Dołęgowska,et al.  Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report , 2014, PloS one.

[96]  R K Jain,et al.  Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.

[97]  Jonathan B. Mitchem,et al.  Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis , 2013, Clinical Cancer Research.

[98]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[99]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.

[100]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[101]  G. Rao,et al.  PLCβ3 mediates cortactin interaction with WAVE2 in MCP1-induced actin polymerization and cell migration , 2015, Molecular biology of the cell.

[102]  V. Koteliansky,et al.  Interference with TGF‐β1 and ‐β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma , 2002, International journal of cancer.

[103]  William J. Polacheck,et al.  Interstitial flow influences direction of tumor cell migration through competing mechanisms , 2011, Proceedings of the National Academy of Sciences.

[104]  M. Talamonti,et al.  Surgical management of pancreatic cancer. , 2005, Seminars in radiation oncology.

[105]  S. Araki,et al.  Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. , 2007, Cancer research.

[106]  D. Graves,et al.  Expression of monocyte chemotactic protein-1 in human melanoma in vivo. , 1992, The American journal of pathology.

[107]  K. Zanker,et al.  Signal processing in migrating T24 human bladder carcinoma cells: Role of the autocrine interleukin‐8 loop , 2002, International journal of cancer.

[108]  D. Kruger,et al.  Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review , 2016, PloS one.

[109]  Ben Fabry,et al.  Bayesian model selection for complex dynamic systems , 2018, Nature Communications.

[110]  R K Jain,et al.  Interstitial hypertension in human breast and colorectal tumors. , 1992, Cancer research.

[111]  An introduction to systems biology , 2003 .

[112]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[113]  Roger D Kamm,et al.  Computational modeling of three-dimensional ECM-rigidity sensing to guide directed cell migration , 2018, Proceedings of the National Academy of Sciences.

[114]  Melody A Swartz,et al.  A driving force for change: interstitial flow as a morphoregulator. , 2007, Trends in cell biology.

[115]  K. Ariyoshi,et al.  Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation. , 2010, Biochemical and biophysical research communications.

[116]  R. Kamm,et al.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. , 2017, Convergent science physical oncology.

[117]  A. Yuan,et al.  Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. , 2000, American journal of respiratory and critical care medicine.

[118]  R. Reed,et al.  Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of 51Cr‐EDTA , 2000, International journal of cancer.

[119]  C. Caux,et al.  Chemokines in cancer. , 2002, Cytokine & growth factor reviews.

[120]  H. Patel,et al.  Chemokines: key players in cancer , 2003, Current medical research and opinion.

[121]  L. Johansson,et al.  Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[122]  B. Mian,et al.  Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. , 2002, The American journal of pathology.

[123]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[124]  Rakesh K Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1997, Advanced drug delivery reviews.

[125]  B. Rollins,et al.  Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. , 1994, Journal of immunology.

[126]  Julia L. Gregory,et al.  Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase , 2011, The Journal of Immunology.

[127]  Triantafyllos Stylianopoulos,et al.  Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.